Australian Statistics on Medicines 2010

Table 1 - General Antiinfectives For Systemic Use

GENERAL ANTIINFECTIVES FOR SYSTEMIC USE

J01 - ANTIBACTERIALS FOR SYSTEMIC USE
J02 - ANTIMYCOTICS FOR SYSTEMIC USE
J04 - ANTIMYCOBACTERIALS
J05 - ANTIVIRALS FOR SYSTEMIC USE
J07 - VACCINES

J01 - ANTIBACTERIALS FOR SYSTEMIC USE
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE TETRACYCLINES TETRACYCLINES
J01AA02	DOXYCYCLINE
	P	2702F	Tablet 100mg (HCl salt after 1 Oct 2007) 28	0.10	GM	62,868	908,276
	P	2703G	Capsule 100mg (as HCl salt after 1 Oct 2007)	0.10	GM	49,413	715,878
	P	2707L	Capsule 50mg (as HCl salt after 1 Oct 2007)	0.10	GM	271,106	2,763,037
	P	2708M	Capsule 100mg (as HCl salt after 1 Oct 2007)	0.10	GM	278,195	2,434,591
	P	2709N	Tablet 100mg (as HCl salt after 1 Oct 2007)	0.10	GM	290,338	2,578,835
	P	2711Q	Tablet 50mg (as HCl salt after 1 Oct 2007) 25	0.10	GM	256,718	2,634,067
	P	2714W	Tablet 100mg (as HCl salt after 1 Oct 2007) 21	0.10	GM	43,711	540,044
	P	2715X	Capsule 100mg (as HCl salt after 1 Oct 2007)	0.10	GM	33,647	419,222
	P	3321T	Tablet 100mg	0.10	GM	3,759	31,837
	P	3322W	Capsule 100mg	0.10	GM	748	6,339
	P	5082L	Tablet 100mg (monohydrate) 7	0.10	GM	519	4,394
	P	9105F	Tablet 100mg (monohydrate) 7	0.10	GM	130,739	1,107,611
	P	9106G	Tablet 50mg (as monohydrate) 25	0.10	GM	193,106	1,948,199
	P	9107H	Tablet 100mg (monohydrate) 28	0.10	GM	26,742	385,398
	P	9108J	Tablet 100mg (as monohydrate) 21	0.10	GM	14,437	178,090
J01AA08	MINOCYCLINE
	P	1616C	Tablet 50mg	0.20	GM	392,429	6,055,631
	P	3037W	Capsule 100mg	0.20	GM	3,020	29,417
BETA-LACTAM ANTIBACTERIALS,PENICILLINS
PENICILLINS WITH EXTENDED SPECTRUM
J01CA04	AMOXYCILLIN
	P	1878W	Sachet containing oral powder 3g	1.00	GM	14,037	137,436
	P	1884E	Capsule 250mg	1.00	GM	348,523	3,006,792
	P	1886G	Powder for syrup 125mg per 5mL 100mL	1.00	GM	625,989	6,790,416
	P	1887H	Powder for syrup 250mg per 5mL 100mL	1.00	GM	1,080,743	12,672,851
	P	1888J	Powder paediatric oral drops 100mg per mL 20mL	1.00	GM	214,157	2,825,269
	P	1889K	Capsule 500mg	1.00	GM	3,161,388	34,074,751
	P	3300Q	Capsule 500mg	1.00	GM	546,426	5,785,536
	P	3301R	Capsule 250mg	1.00	GM	48,429	413,895
	P	3302T	Powder for syrup 125mg per 5mL 100mL	1.00	GM	11,231	121,770
	P	3309E	Sachet containing oral powder 3g	1.00	GM	26,051	237,331
	P	3393N	Powder for syrup 250mg per 5mL 100mL	1.00	GM	16,521	193,098
	P	5225B	Powder for oral suspension 500mg per 5mL 100mL	1.00	GM	254	3,738
	P	8581P	Tablet 1g 14	1.00	GM	186,253	2,021,743
	P	8705E	Powder for oral suspension 500mg per 5mL 100mL	1.00	GM	47,745	705,961
	P	9714G	Powder paediatric oral drops 100mg per mL 20mL	1.00	GM	157	306
J01CA01	AMPICILLIN
	P	2977Q	Injection 1g (solvent required)	2.00	GM	6,984	118,724
BETA-LACTAMASE SENSITIVE PENICILLINS
J01CE08	BENZATHINE PENICILLIN
	P	2267H	Injection 900mg in 2.3mL cartridge-needle unit	3.60	GM	1,441	374,846

J01 - ANTIBACTERIALS FOR SYSTEMIC USE
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE BETA-LACTAM ANTIBACTERIALS,PENICILLINS
J01CE10	BENZATHINE PHENOXYMETHYLPENICILLIN
	P	5012T	Oral suspension 150mg per 5mL 100mL	2.00	GM	223	4,016
	P	9143F	Oral suspension 150mg per 5mL 100mL	2.00	GM	162,229	3,549,102
J01CE01	BENZYLPENICILLIN
	P	1775K	Injection 600mg (solvent required)	3.60	GM	5,770	515,647
	P	2647H	Injection 3g (solvent required)	3.60	GM	1,730	180,901
	P	3486L	Injection 600mg (with sterilised water)	3.60	GM	2,259	85,502
	P	3487M	Injection 3g (solvent supplied)	3.60	GM	1,738	22,161
J01CE02	PHENOXYMETHYLPENICILLIN
	P	1703P	Tablet 250mg	2.00	GM	10,047	116,453
	P	1705R	Capsule 250mg	2.00	GM	30,129	343,883
	P	1787C	Tablet 250mg	2.00	GM	23,405	263,655
	P	1789E	Capsule 250mg	2.00	GM	27,308	309,026
	P	2965C	Capsule 500mg	2.00	GM	261,236	3,627,854
	P	3028J	Tablet 500mg	2.00	GM	114,288	1,570,076
	P	3360W	Tablet 250mg	2.00	GM	1,768	16,345
	P	3361X	Tablet 500mg	2.00	GM	3,334	35,427
	P	3363B	Capsule 250mg	2.00	GM	1,508	15,451
	P	3364C	Capsule 500mg	2.00	GM	7,322	85,955
J01CE09	PROCAINE PENICILLIN
	P	1794K	Injection 1.5g	0.60	GM	6,811	628,423
	P	3485K	Injection 1.5g	3.60	GM	18,428	1,698,539
BETA-LACTAMASE RESISTANT PENICILLINS
J01CF01	DICLOXACILLIN
	P	8121K	Capsule 250mg	2.00	GM	27,298	320,220
	P	8122L	Capsule 500mg	2.00	GM	308,813	5,966,086
J01CF05	FLUCLOXACILLIN
	P	1524F	Injection 500mg (solvent required)	2.00	GM	168	2,945
	P	1525G	Injection 1g (solvent required)	2.00	GM	14,239	747,825
	P	1526H	Capsule 250mg	2.00	GM	60,503	717,302
	P	1527J	Capsule 500mg	2.00	GM	403,651	7,760,583
	A	20436	Powder for syrup 250mg per 5mL 100mL	2.00	GM	246	—
	P	5091Y	Capsule 500mg	2.00	GM	251	4,221
	P	9149M	Powder for oral liquid 125mg per 5mL 100mL	2.00	GM	20,171	336,533
	P	9150N	Powder for oral liquid 250mg per 5mL 100mL	2.00	GM	52,808	1,213,068
COMBINATIONS OF PENICILLINS, INCL.BETA-LACTAMASE INHIBITORS
J01CR02	AMOXYCILLIN with CLAVULANIC ACID
	P	1891M	Tablet 500mg-125mg	1.00	GM	460,268	5,696,561
	P	1892N	Powder for syrup 125mg-31.25mg per 5mL 75mL	1.00	GM	70,821	890,601
	P	5006L	Tablet 875mg-125mg	1.00	GM	55,496	808,911
	P	5008N	Tablet 500mg-125mg	1.00	GM	13,057	158,768
	P	5011R	Powder for syrup 400mg-57mg per 5mL 50mL	1.00	GM	265	3,700
	P	8254K	Tablet 875mg-125mg	1.00	GM	2,998,928	44,786,759

J01 - ANTIBACTERIALS FOR SYSTEMIC USE
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE BETA-LACTAM ANTIBACTERIALS,PENICILLINS
	P	8319W	Powder for syrup 400mg-57mg per 5mL 50mL	1.00	GM	474,874	6,967,080
J01CR03	TICARCILLIN with CLAVULANIC ACID
	P	2179Q	Injection 3g-100mg (solvent required)	15.00	GM	26,876	4,531,387
	P	6884H	Injection 3g-100mg 10mL and NS	15.00	GM	6,358	1,307,556
OTHER BETA-LACTAM ANTIBACTERIALS
FIRST-GENERATION CEPHALOSPORINS
J01DB01	CEFALEXIN
	P	3058Y	Capsule 250mg	2.00	GM	328,468	2,978,469
	P	3094W	Granules for syrup 125mg per 5mL 100mL	2.00	GM	154,939	1,838,661
	P	3095X	Granules for syrup 250mg per 5mL 100mL	2.00	GM	452,311	6,155,727
	P	3119E	Capsule 500mg	2.00	GM	3,887,208	42,513,364
	P	3317N	Capsule 250mg	2.00	GM	3,126	27,657
	P	3318P	Capsule 500mg	2.00	GM	30,173	324,147
	P	3320R	Granules for syrup 250mg per 5mL 100mL	2.00	GM	1,117	14,802
J01DB03	CEFALOTHIN
	P	2964B	Injection 1g (solvent required)	4.00	GM	32,373	1,127,035
J01DB04	CEPHAZOLIN
	P	1257E	Injection 1g (solvent required)	3.00	GM	30,534	1,904,261
	P	9326W	Powder for injection 2g 10	3.00	GM	525	99,774
SECOND-GENERATION CEPHALOSPORINS
J01DC04	CEFACLOR
	P	1169M	Tablet 375mg (sustained release)	1.00	GM	584,382	7,632,949
	P	2460L	Powder for oral susp 125mg per 5mL 100mL	1.00	GM	118,005	1,592,874
	P	2461M	Powder for oral susp 250mg per 5mL 75mL	1.00	GM	279,132	3,879,351
	P	5045M	Tablet 375mg (sustained release)	1.00	GM	2,384	30,748
	P	5047P	Powder for oral susp 250mg per 5mL 75mL	1.00	GM	226	3,130
J01DC02	CEFUROXIME
	P	8292K	Tablet 250mg 14	0.50	GM	111,342	2,170,969
THIRD-GENERATION CEPHALOSPORINS
J01DD01	CEFOTAXIME
	P	1085D	Injection 1g (solvent required)	4.00	GM	1,327	33,373
	P	1086E	Injection 2g (solvent required)	4.00	GM	316	13,758
J01DD04	CEFTRIAXONE
	P	1784X	Injection 1g (solvent required)	2.00	GM	50,550	1,855,294
	P	1785Y	Injection 2g (solvent required)	2.00	GM	6,087	395,406
	A	18777	Injection 1g (solvent required)	2.00	GM	118	—
	P	9058R	Injection 500mg (solvent required)	2.00	GM	2,009	20,848
FOUTH-GENERATION CEPHALOSPORINS
J01DE01	CEFEPIME
	P	8315P	Injection 1g (solvent required)	2.00	GM	431	99,516
	P	8316Q	Injection 2g (solvent required)	2.00	GM	327	156,854
SULFONAMIDES AND TRIMETHOPRIM
TRIMETHOPRIM AND DERIVATIVES

J01 - ANTIBACTERIALS FOR SYSTEMIC USE
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE SULFONAMIDES AND TRIMETHOPRIM
J01EA01	TRIMETHOPRIM
	P	2922T	Tablet 300mg	0.40	GM	803,856	6,951,346
COMBINATIONS OF SULFONAMIDES AND TRIMETHOPRIM, INCL. DERIVATIVES
J01EE01	TRIMETHOPRIM with SULPHAMETHOXAZOLE
	P	2949F	Tablet 80mg-400mg	—	—	5,368	56,547
	P	2951H	Tablet 160mg-800mg	—	—	336,516	3,496,145
	P	3103H	Oral suspension 40mg-200mg per 5mL 100mL	—	—	109,789	1,018,575
	P	3390K	Tablet 160mg-800mg	—	—	1,120	10,499
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
MACROLIDES
J01FA10	AZITHROMYCIN
	A	19032	Tablet 500mg 3	0.30	GM	113,272	—
	A	20776	Tablet 500mg 3	0.30	GM	3,126	—
	P	4115N	Tablet 500mg	0.30	GM	6,342	307,965
	P	6221K	Tablet 600mg 16	0.30	GM	130	7,042
	P	8200N	Tablet 500mg	0.30	GM	59,752	1,298,229
	P	8201P	Powder for oral suspension 200mg per 5mL 15mL	0.30	GM	7,228	155,282
	P	8336R	Tablet 500mg 2	0.30	GM	53,535	1,146,601
J01FA09	CLARITHROMYCIN
	P	6151R	Tablet 250mg 100	0.50	GM	155	5,995
	P	6152T	Tablet 500mg 100	0.50	GM	318	24,547
	P	8318T	Tablet 250mg 14	0.50	GM	920,843	12,001,794
	P	9192T	Powder for oral liquid 250mg per 5mL 50mL	0.50	GM	30,058	1,151,995
J01FA01	ERYTHROMYCIN
	P	1397M	I.V. infusion 1g (base)	1.00	GM	678	59,936
	P	1404X	Capsule 250mg	1.00	GM	152,492	1,500,061
	P	2424N	Granules for paediatric oral susp 200mg	1.00	GM	181,728	2,246,220
	P	2428T	Granules for oral susp 400mg (base) per 5mL 10	1.00	GM	211,331	2,855,863
	P	2750R	Tablet 400mg (base)	1.00	GM	479,804	5,388,028
	P	3325B	Capsule 250mg	1.00	GM	14,965	140,848
	P	3334L	Granules for paediatric oral suspension 200mg	1.00	GM	215	2,644
	P	3336N	Tablet 400mg (base)	1.00	GM	7,321	79,620
J01FA06	ROXITHROMYCIN
	P	1760P	Tablet 150mg 10	0.30	GM	930,040	11,110,824
	P	5260W	Tablet 150mg 10	0.30	GM	461	5,416
	P	5261X	Tablet 300mg 5	0.30	GM	532	6,255
	P	8016X	Tablet 300mg 5	0.30	GM	1,317,252	15,879,330
	P	8129W	Tablet for oral suspension 50mg 10	0.30	GM	83,614	1,123,552
LINCOSAMIDES
J01FF01	CLINDAMYCIN
	P	3138E	Capsule 150mg	1.20	GM	147,925	5,187,012
	P	5057E	Capsule 150mg	1.20	GM	40,968	800,021
J01FF02	LINCOMYCIN

J01 - ANTIBACTERIALS FOR SYSTEMIC USE
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
	P	2530E	Injection 600mg in 2mL	1.80	GM	3,622	134,768
AMINOGLYCOSIDE ANTIBACTERIALS
OTHER AMINOGLYCOSIDES
J01GB03	GENTAMICIN SULPHATE
	P	2824P	Injection 80mg (base) in 2mL	0.24	GM	18,843	393,873
J01GB01	TOBRAMYCIN
	P	1356J	Injection 80mg (base)	0.24	GM	2,556	297,252
	P	8872Y	Injection 80mg (base) in 2mL (without preserv)	0.24	GM	1,313	158,992
QUINOLONE ANTIBACTERIALS
FLUOROQUINOLONES
J01MA02	CIPROFLOXACIN
	P	1208N	Tablet 250mg	1.00	GM	18,228	733,422
	P	1209P	Tablet 500mg	1.00	GM	143,917	9,556,428
	P	1210Q	Tablet 750mg	1.00	GM	40,256	4,312,012
	P	1311B	Tablet 250mg	1.00	GM	824	10,068
	A	21046	Tablet 250mg 2	1.00	GM	749	—
J01MA14	MOXIFLOXACIN
	A	20350	Tablet 400mg 5	0.40	GM	4,371	—
J01MA06	NORFLOXACIN
	A	13660	Tablet 400mg 6	0.80	GM	49,340	—
	P	3010K	Tablet 400mg	0.80	GM	223,726	4,632,759
OTHER ANTIBACTERIALS
GLYCOPEPTIDE ANTIBACTERIALS
J01XA01	VANCOMYCIN
	P	2269K	Powder for injection 1gm (1000000iu) 1	2.00	GM	652	44,072
	P	2270L	Powder for injection 1gm (1000000iu) 3	2.00	GM	19,843	1,617,672
	P	3130R	Injection 500mg (500000iu) (solvent required)	2.00	GM	237	9,546
	P	3131T	Injection 500mg (500000iu) (solvent required)	2.00	GM	10,962	804,328
STEROID ANTIBACTERIALS
J01XC01	FUSIDIC ACID
	P	2312Q	Tablet (sodium salt) 250mg (enteric coated)	1.50	GM	20,498	3,953,262
IMIDAZOLE DERIVATIVES
J01XD01	METRONIDAZOLE
	P	1638F	I.V. infusion 500mg in 100mL	1.50	GM	14,468	448,041
NITROFURAN DERIVATIVES
J01XE01	NITROFURANTOIN
	P	1692C	Capsule 50mg	0.20	GM	65,773	1,345,482
	P	1693D	Capsule 100mg	0.20	GM	94,127	2,493,514
OTHER ANTIBACTERIALS
J01XX05	HEXAMINE HIPPURATE
	P	3124K	Tablet 1g	2.00	GM	87,666	3,709,051

tr class='row-even'>

J02 - ANTIMYCOTICS FOR SYSTEMIC USE
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE IMIDAZOLE DERIVATIVES
J02AB02	KETOCONAZOLE
	P	1572R	Tablet 200mg	0.20	GM	21,616	943,683
	P	1573T	Tablet 200mg	0.20	GM	28,926	621,642
TRIAZOLE DERIVATIVES
J02AC01	FLUCONAZOLE
	A	14171	Capsule 150mg 1	0.20	GM	6,272	—
	P	1471K	Capsule 50mg 28	0.20	GM	5,187	465,382
	P	1472L	Capsule 100mg 28	0.20	GM	10,020	1,721,255
	P	1474N	Solution for IV infusion 200mg in 100mL 7	0.20	GM	653	325,021
	P	1475P	Capsule 200mg	0.20	GM	11,708	4,062,557
	A	19776	Capsule 150mg 1	0.20	GM	863	—
	A	19901	Capsule 150mg 1	0.20	GM	1,391	—
	A	19919	Capsule 150mg 1	0.20	GM	366	—
	A	20244	Capsule 150mg 1	0.20	GM	871	—
	A	20517	Capsule 150mg 1	0.20	GM	636	—
	A	20660	Capsule 150mg 1	0.20	GM	352	—
	A	20799	Capsule 150mg 1	0.20	GM	1,692	—
J02AC02	ITRACONAZOLE
	A	14810	Capsule 100mg	0.20	GM	2,133	—
	A	16227	Capsule 100mg 28	0.20	GM	1,778	—
	P	8196J	Capsule 100mg	0.20	GM	6,874	2,203,793
J02AC04	POSACONAZOLE
	P	9360P	Oral suspension 40mg/mL 105, 1	0.80	GM	1,577	4,846,571
J02AC03	VORICONAZOLE
	P	9363T	Tablet 50mg 56	0.40	GM	603	731,571
	P	9364W	Tablet 200mg 56	0.40	GM	2,660	7,266,349

J04 - ANTIMYCOBACTERIALS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIMYCOBACTERIALS DRUGS FOR TREATMENT OF TUBERCULOSIS ANTIBIOTICS
J04AB04	RIFABUTIN
	P	6195C	Capsule 150mg 120	0.15	GM	198	7,817
J04AB02	RIFAMPICIN
	P	1981G	Capsule 150mg	0.60	GM	881	11,790
	P	1982H	Capsule 150mg	0.60	GM	590	19,877
	P	1983J	Capsule 300mg	0.60	GM	2,020	124,256
	P	1984K	Capsule 300mg	0.60	GM	7,258	115,817
	P	8025J	Syrup 100mg per 5mL 60mL	0.60	GM	441	19,194
HYDRAZIDES
J04AC01	ISONIAZID
	P	1554T	Tablet 100mg	0.30	GM	1,782	20,942
DRUGS FOR TREATMENT OF LEPRA
DRUGS FOR TREATMENT OF LEPRA
J04BA02	DAPSONE
	P	1272Y	Tablet 100mg	50.00	MG	3,138	348,317
	P	8801F	Tablet 25mg	50.00	MG	2,146	215,927

J05 - ANTIVIRALS FOR SYSTEMIC USE
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIVIRALS FOR SYSTEMIC USE DIRECT ACTING ANTIVIRALS NUCLEOSIDES AND NUCLEOTIDES EXCL. REVERSE TRANSCRIPTASE INHIBITORS
J05AB01	ACICLOVIR
	P	1003T	Tablet 200mg	4.00	GM	4,689	324,459
	P	1007B	Tablets 200mg 90	4.00	GM	29,426	3,640,036
	P	1052J	Tablets 800mg 35	4.00	GM	8,820	1,293,455
	P	8234J	Tablets 800mg 120	4.00	GM	151	65,072
J05AB09	FAMCICLOVIR
	A	19696	Tablet 250mg 14	0.75	GM	236	—
	A	19996	Tablet 500mg 3	0.75	GM	58,131	—
	A	21238	Tablet 500mg 3	0.75	GM	4,474	—
	A	21347	Tablet 500mg 3	0.75	GM	441	—
	P	2274Q	Tablet 250mg 20	0.75	GM	14,339	1,980,874
	P	8002E	Tablet 250mg	0.75	GM	55,661	7,930,903
	P	8092X	Tablet 125mg	0.75	GM	7,149	976,132
	P	8217L	Tablet 250mg	0.75	GM	78,862	28,203,214
	P	8896F	Tablet 500mg 56	0.75	GM	4,805	1,715,395
	P	8897G	Tablet 500mg 30	0.75	GM	2,815	564,992
J05AB11	VALACICLOVIR
	A	20467	Tablet 1000mg 4	3.00	GM	6,467	—
	P	8064K	Tablet 500mg 42	3.00	GM	38,334	8,195,550
	P	8133C	Tablet 500mg 20	3.00	GM	18,264	1,935,118
	P	8134D	Tablet 500mg 30	3.00	GM	349,094	58,581,758
J05AB14	VALGANCICLOVIR
	P	6357N	Tablet 450mg (base) 120	0.90	GM	162	448,833
NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AF08	ADEFOVIR DIPIVOXIL
	P	6450L	Tablet 30mg 60	10.00	MG	4,111	3,212,507
J05AF02	DIDANOSINE
	P	6300N	Capsule 250mg (enteric coated beads) 60	0.40	GM	198	—
	P	6301P	Capsule 400mg (enteric coated beads) 60	0.40	GM	140	51,432
J05AF10	ENTECAVIR
	P	9602J	Tablet 0.5mg 60	0.50	MG	14,929	7,527,048
	P	9603K	Tablet 1mg 60	0.50	MG	3,039	2,374,600
J05AF05	LAMIVUDINE
	P	6193Y	Tablet 150mg 120	0.30	GM	344	48,846
	P	6257H	Tablet 100mg 56	0.30	GM	6,967	1,328,523
	P	6435Q	Tablet 300mg 60	0.30	GM	509	—
J05AF04	STAVUDINE
	P	6190T	Capsule 40mg 120	80.00	MG	195	—
J05AF07	TENOFOVIR
	P	6358P	Tablet containing tenofovir disoproxil fumarate 300mg 60	0.25	GM	8,098	5,112,416
J05AF01	ZIDOVUDINE
	P	6154X	Capsule 250mg 240	0.60	GM	182	—

J05 - ANTIVIRALS FOR SYSTEMIC USE
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIVIRALS FOR SYSTEMIC USE DIRECT ACTING ANTIVIRALS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AG03	EFAVIRENZ
	P	6356M	Tablet 600mg 60	0.60	GM	201	85,837
J05AG01	NEVIRAPINE
	P	6215D	Tablet 200mg 120	0.40	GM	5,220	1,833,334
NEURAMINIDASE INHIBITORS
J05AH02	OSELTAMIVIR
	A	17034	Capsule 75mg 10	—	—	28,267	—
	A	20830	Capsule 30mg 10	0.15	GM	144	—
J05AH01	ZANAMIVIR
	A	16327	Rotadisk 5mg 20	20.00	MG	1,034	—
ANTIVIRALS FOR TREATMENT OF HIV INFECTION, COMBINATIONS
J05AR	LOPINAVIR with RITONAVIR
	P	6495W	Tablet 200mg-50mg 240	—	—	4,445	3,748,601
J05AR03	TENOFOVIR with EMTRICITABINE
	P	6468K	Tablet containing tenofovir disoproxil fumarate 300mg with emtricitabine 200mg 60	—	—	362	326,170
J05AR06	TENOFOVIR with EMTRICITABINE and EFAVIRENZ
	P	9650X	Tablet containing tenofovir disoproxil fumarate 300mg with emtricitabine 200mg and efavirenz 600mg 60	—	—	145	230,697
J05AR01	ZIDOVUDINE and LAMIVUDINE
	P	6234D	Tablet 150mg-300mg 120	—	—	1,570	1,036,261
J05AR04	ZIDOVUDINE with LAMIVUDINE with ABACAVIR
	P	6327B	Tablet 300mg-150mg-300mg (as sulfate) 120	—	—	574	—

J07 - VACCINES
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE VACCINES BACTERIAL VACCINES CHOLERA VACCINES
J07AE01	CHOLERA
	A	20362	Oral granules inactivated choleme 2	—	—	21,661	—
J07AE02	CHOLERA, LIVE ATTENUATED
	A	18382	Oral granules Cholera, inactivated 14	—	—	19,345	—
MENINGOCOCCAL VACCINES
J07AH04	MENINGOCOCCAL
	A	14507	Vial 0.5mL 1	—	—	6,417	—
	A	15130	Vial 0.5mL 1	—	—	223	—
J07AH07	MENINGOCOCCAL C
	A	17391	Vial 0.5mL 1	—	—	271	—
	A	17637	Syringe 10ug per 0.5mL conjugated 1	—	—	113	—
	A	20145	Injection 10mg per 0.5mL prefilled syringe 1	—	—	172	—
PERTUSSIS VACCINES
J07AJ52	DIPHTERIA with TETANUS with PERTUSSIS PURIFIED ANTIGEN
	A	17092	Injection 0.5mL 1	—	—	59,691	—
J07AJ51	DIPHTHERIA, TETANUS and PERTUSSIS VACCINE, ADSORBED
	A	19778	Injection 0.5mL	—	—	12,111	—
PNEUMOCOCCAL VACCINES
J07AL01	PNEUMOCOCCAL
	P	1903E	Injection 0.5mL (23 valent)	—	—	19,582	900,570
TETANUS VACCINES
J07AM51	TETANUS TOXOID, COMBINATIONS with DIPTHERIA
	P	3463G	Injection 0.5mL in pre-filled syringe	—	—	26,803	5,767,020
	P	8783G	Injection 0.5mL in pre-filled syringe	—	—	7,936	488,370
TYPHOID,VACCINES
J07AP01	SALMONELLA-TYPHI
	A	19176	Oral live attenuated capsule Typhoid	—	—	5,317	—
J07AP03	TYPHOID PURIFIED POLYSACCHARIDE ANTIGEN
	A	14718	Syringe 0.5mL	—	—	83,514	—
	A	16719	Injection 25ug	—	—	24,528	—
VIRAL VACCINES
ENCEPHALITIS VACCINES
J07BA02	JAPANESE ENCEPHALITIS VACCINE
	A	20716	Pre-filled syringe 0.5mL	—	—	221	—
INFLUENZA VACCINES
J07BB02	INFLUENZA VACCINE
	A	20834	Injection 0.1mL	—	—	25,207	—
	A	21010	Injection (trivalent) 0.5mL	—	—	107,507	—
	A	21011	Injection (trivalent) 0.25mL	—	—	367	—
	A	21012	Injection (trivalent) 0.5mL	—	—	88,773	—
	A	21013	Injection (trivalent) 0.5mL	—	—	21,973	—
	P	2852D	Injection (trivalent) 0.5mL	—	—	26,939	26,245

J07 - VACCINES
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE VACCINES VIRAL VACCINES HEPATITIS VACCINES
J07BC02	HEPATITIS A
	A	15677	Syringe 720u/0.5mL	—	—	29,264	—
	A	15687	Syringe 144u 1	—	—	59,347	—
	A	15770	Syringe 25u 1	—	—	421	—
	A	17617	Vial 0.5mL 1	—	—	181	—
J07BC20	HEPATITIS A\HEPATITIS B
	A	15760	Syringe 1mL	—	—	92,279	—
	A	15917	Syringe 0.5mL	—	—	1,623	—
	A	17055	Syringe 0.5mL	—	—	980	—
J07BC01	HEPATITIS B
	A	12913	Vial 1mL 1	—	—	252	—
	A	13026	Ampoule 20ug per mL 1	—	—	53,822	—
	A	13473	Ampoule 10ug per 0.5mL 1	—	—	1,528	—
	A	20760	Pre-filled syringe 20ug per mL 1	—	—	19,168	—
	A	20833	Pre-filled syringe 10ug per 0.5mL 1	—	—	507	—
J07BC20	SALMONELLA and HEPATITIS A
	A	17818	Prefilled syringe 25ug and 160 Elisa units	—	—	105,658	—
MEASLES VACCINES
J07BD52	MEASLES with MUMPS with RUBELLA
	A	18509	Injection 0.5mL 1	—	—	6,947	—
POLIOMYELITIS VACCINES
J07BF03	POLIOMYELITIS
	A	16235	Injection 0.5mL	—	—	7,084	—
RABIES VACCINES
J07BG01	RABIES INACTIVATED
	A	14107	Injection 1mL 1	—	—	1,819	—
	A	19166	Injection 2.5ug 1	—	—	2,232	—
RUBELLA VACCINES
J07BJ01	RUBELLA
	A	11227	Injection 0.5mL	—	—	146	—
VARICELLA VACCINES
J07BK01	VARICELLA LIVE ATTENUATED
	A	16723	Vaccine 0.5mL	—	—	6,701	—
	A	17821	Vaccine 0.5mL	—	—	147	—
PAPILLOMAVIRUS VACCINES
J07BM02	VACCINE PAPILLOMAVIRUS (HUMAN TYPES 16 and 18)
	A	20142	Injection 0.5mL prefilled syringe 1	—	—	1,952	—
J07BM01	VACCINE PAPILLOMAVIRUS (HUMAN TYPES 6, 11, 16 and 18)
	A	10756	Injection 0.5mL prefilled syringe 1	—	—	5,508	—
BACTERIAL AND VIRAL VACCINES, COMBINED
BACTERIAL AND VIRAL VACCINES, COMBINED
J07CA02	DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS

- VACCINES
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE VACCINES BACTERIAL AND VIRAL VACCINES, COMBINED
	A	19175	Injection 0.5mL, 1	—	—	31,479	—
	A	20236	Injection 0.5mL syringe	—	—	2,309	—

Australian Statistics on Medicines 2010

Table 1 - General Antiinfectives For Systemic Use

Department of Health and Aged Care

Pharmaceutical Benefits Scheme

PBS Information

Browse the PBS

For Health Professionals

For Industry